Improving cancer detection and monitoring through advanced imaging techniques
Quantitative in-vivo and clinical imaging (Boppart)
['FUNDING_OTHER'] · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · NIH-10910244
This study is working on new imaging techniques that can help doctors spot and track diseases like cancer more accurately and safely, without using harmful dyes, so patients can get better care and treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN (nih funded) |
| Locations | 1 site (CHAMPAIGN, UNITED STATES) |
| Trial ID | NIH-10910244 on ClinicalTrials.gov |
What this research studies
This research focuses on developing advanced imaging technologies that can enhance the detection, diagnosis, and monitoring of diseases, particularly cancer. It aims to create label-free imaging methods that can provide reliable signals indicating changes in tissue structure and function without the need for potentially harmful contrast agents. By identifying biomarkers that reflect the underlying pathology, this approach seeks to improve the accuracy and efficiency of clinical imaging in real-time settings. Patients may benefit from more precise and safer imaging techniques that could lead to better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing evaluation for cancer or those requiring monitoring of known cancerous conditions.
Not a fit: Patients with conditions that do not involve cancer or require imaging for other non-cancerous diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective imaging techniques for cancer detection and monitoring.
How similar studies have performed: Previous research has shown promise in the development of label-free imaging techniques, indicating potential for success in this novel approach.
Where this research is happening
CHAMPAIGN, UNITED STATES
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN — CHAMPAIGN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOPPART, STEPHEN A — UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
- Study coordinator: BOPPART, STEPHEN A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Detection